{"id":"neutral-protamine-hagedorn-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"NPH (Neutral Protamine Hagedorn) insulin is a suspension of insulin crystals complexed with protamine, which slows insulin absorption from subcutaneous tissue compared to regular insulin. This results in an intermediate duration of action (10-16 hours) with a peak effect around 4-8 hours. It mimics the basal insulin secretion pattern and is used to control fasting and between-meal blood glucose levels in diabetes management.","oneSentence":"NPH insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:34:57.689Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT06619301","phase":"PHASE3","title":"RCT Glargine vs NPH for Treatment of DM in Pregnancy","status":"RECRUITING","sponsor":"Loyola University","startDate":"2024-04-01","conditions":"Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2","enrollment":160},{"nctId":"NCT05124457","phase":"PHASE2","title":"DETERMINE: Detemir vs NPH","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-02-01","conditions":"Gestational Diabetes, Diabetes Mellitus, Type 2","enrollment":336},{"nctId":"NCT05709938","phase":"PHASE4","title":"Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2019-11-01","conditions":"To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children","enrollment":68},{"nctId":"NCT02967224","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulins in Insulin Naïve Patients Initiating Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-05","conditions":"Diabetes Mellitus, Type 2","enrollment":705},{"nctId":"NCT02967211","phase":"PHASE4","title":"A \"Real World\" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to \"Standard of Care\" Basal Insulin in Patients Already Using Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-12-21","conditions":"Diabetes Mellitus, Type 2","enrollment":609},{"nctId":"NCT03620890","phase":"PHASE4","title":"Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-09-04","conditions":"Diabetes Mellitus, Type 2","enrollment":108},{"nctId":"NCT03389490","phase":"PHASE4","title":"Toujeo Versus NPH Self-titration Study","status":"COMPLETED","sponsor":"Elaine Chow","startDate":"2018-01-01","conditions":"Diabetes Mellitus, Type 2","enrollment":50},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04690309","phase":"PHASE4","title":"Human Versus Analogue Insulin in Patients After Pancreatectomy.","status":"UNKNOWN","sponsor":"Polish Society of Diabetology","startDate":"2018-07-01","conditions":"Pancreatogenous Diabetes","enrollment":100},{"nctId":"NCT02486341","phase":"NA","title":"Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2016-03-31","conditions":"Diabetes","enrollment":30},{"nctId":"NCT03511521","phase":"PHASE4","title":"Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2018-03-27","conditions":"Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes","enrollment":3},{"nctId":"NCT04034524","phase":"","title":"Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2019-05-01","conditions":"Diabetes Mellitus, Type 2","enrollment":20000},{"nctId":"NCT02634528","phase":"PHASE1","title":"Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal","status":"COMPLETED","sponsor":"Julphar Gulf Pharmaceutical Industries","startDate":"2016-11-16","conditions":"Diabetes Mellitus","enrollment":85},{"nctId":"NCT00564018","phase":"NA","title":"Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2006-09","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT01683331","phase":"PHASE4","title":"A Clinical Trial to Prevent New Onset Diabetes After Transplantation","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-08","conditions":"Prevention of New Onset Diabetes Among Kidney Transplant Patients","enrollment":251},{"nctId":"NCT02131272","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2014-06-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT01184014","phase":"PHASE4","title":"Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2010-08","conditions":"Hyperglycemia","enrollment":72},{"nctId":"NCT02012465","phase":"EARLY_PHASE1","title":"Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-09","conditions":"Lymphoma, Diabetes Mellitus, Type 2, Hyperglycemia","enrollment":15},{"nctId":"NCT02302716","phase":"PHASE3","title":"A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-12","conditions":"Diabetes Mellitus, Type 2","enrollment":493},{"nctId":"NCT02189395","phase":"PHASE4","title":"Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting","status":"TERMINATED","sponsor":"Riverside University Health System Medical Center","startDate":"2013-04","conditions":"Type 2 Diabetes Mellitus","enrollment":52},{"nctId":"NCT01798706","phase":"PHASE3","title":"Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2013-06","conditions":"Type 2 Diabetes","enrollment":350},{"nctId":"NCT00474045","phase":"PHASE3","title":"Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-05","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":470},{"nctId":"NCT00832182","phase":"PHASE3","title":"Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1999-12-22","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":75},{"nctId":"NCT02222623","phase":"NA","title":"The Inova Type 2 Diabetes Mellitus Study","status":"WITHDRAWN","sponsor":"Inova Health Care Services","startDate":"2015-04","conditions":"Diabetes, Type 2","enrollment":""},{"nctId":"NCT00795600","phase":"PHASE4","title":"Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-04","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":60},{"nctId":"NCT01648218","phase":"PHASE4","title":"Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia","status":"TERMINATED","sponsor":"Vancouver General Hospital","startDate":"2012-08","conditions":"Post-Transplant Glucocorticoid Induced Diabetes","enrollment":5},{"nctId":"NCT01240785","phase":"PHASE4","title":"Metformin Versus Insulin in Gestational Diabetes","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2006-06","conditions":"Gestational Diabetes","enrollment":221},{"nctId":"NCT00694122","phase":"PHASE3","title":"Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2005-06","conditions":"Type 1 Diabetes, Dawn Phenomenon","enrollment":27},{"nctId":"NCT01223131","phase":"PHASE3","title":"Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-02","conditions":"Type 1 Diabetes Mellitus","enrollment":162},{"nctId":"NCT01358435","phase":"PHASE1","title":"Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects","status":"COMPLETED","sponsor":"Wockhardt","startDate":"2011-01","conditions":"Diabetes Mellitus","enrollment":53},{"nctId":"NCT00941369","phase":"PHASE4","title":"Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2009-06","conditions":"Diabetes Mellitus, Type 2","enrollment":345},{"nctId":"NCT00993473","phase":"PHASE3","title":"6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2009-10","conditions":"Type 1 Diabetes Mellitus","enrollment":125},{"nctId":"NCT00626080","phase":"NA","title":"Insulin Detemir Action in Cerebro","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2009-01","conditions":"Type 1 Diabetes","enrollment":40},{"nctId":"NCT01310452","phase":"NA","title":"Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2011-01","conditions":"Type 2 Diabetes Mellitus","enrollment":50},{"nctId":"NCT00139659","phase":"PHASE3","title":"A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Asthma, Diabetes Mellitus","enrollment":288},{"nctId":"NCT00138671","phase":"PHASE3","title":"A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD","status":"TERMINATED","sponsor":"Pfizer","startDate":"2003-01","conditions":"Diabetes Mellitus, Chronic Obstructive Pulmonary Disease","enrollment":105},{"nctId":"NCT00941148","phase":"PHASE4","title":"Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin","status":"COMPLETED","sponsor":"ikfe-CRO GmbH","startDate":"2008-04","conditions":"Type 2 Diabetic Patients, Insufficient Metabolic Control, OAD Treatment","enrollment":30},{"nctId":"NCT00747409","phase":"PHASE4","title":"Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes","status":"UNKNOWN","sponsor":"Munich Municipal Hospital","startDate":"2004-07","conditions":"Type 2 Diabetes Mellitus","enrollment":120},{"nctId":"NCT00490854","phase":"PHASE2, PHASE3","title":"A Study for Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-07","conditions":"Diabetes Mellitus, Type 2","enrollment":129}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"CARDIAC ARREST"},{"count":6,"reaction":"DRUG INTERACTION"},{"count":5,"reaction":"SEIZURE"},{"count":5,"reaction":"TOXICITY TO VARIOUS AGENTS"},{"count":4,"reaction":"OVERDOSE"},{"count":3,"reaction":"VOMITING"},{"count":2,"reaction":"ACCIDENTAL OVERDOSE"},{"count":2,"reaction":"COMA"},{"count":2,"reaction":"HYPERKALAEMIA"},{"count":2,"reaction":"INTRACARDIAC THROMBUS"}],"_approvalHistory":[],"publicationCount":178,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Neutral protamine hagedorn insulin","genericName":"Neutral protamine hagedorn insulin","companyName":"Eli Lilly and Company","companyId":"eli-lilly","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NPH insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}